Pink Sheet is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

PhRMA Launching National Patient Assistance Clearinghouse April 5

This article was originally published in The Pink Sheet Daily

Executive Summary

The Partnership for Patient Assistance will launch a nationwide campaign to enroll uninsured patients in prescription drug support plans. The program will feature a website and call center modeled on “pilots” conducted in three states; it will direct patients to 275 different manufacturer, government or third-party supported programs.

You may also be interested in...



Together Rx Patient Assistance Program Will Close When ACA Coverage Expansion Begins

The move to shutter the program is noteworthy because it suggests the beginning of a trend among patient assistance programs for drugs as the uninsured gain coverage through state marketplaces or Medicaid.

DTC Ads Should Include Patient Assistance Info, PhRMA's Tauzin Says

Every DTC ad should provide information on the Partnership for Prescription Assistance, Tauzin says in a speech to the Competitive Enterprise Institute. Industry must meet the social obligations that come with the free market system, he says.

DTC Ads Should Include Patient Assistance Info, PhRMA's Tauzin Says

Every DTC ad should provide information on the Partnership for Prescription Assistance, Tauzin says in a speech to the Competitive Enterprise Institute. Industry must meet the social obligations that come with the free market system, he says.

Related Content

Topics

UsernamePublicRestriction

Register

OM013214

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel